Koyfin Home > Directory > Health Care > Antares Pharma > Cash and Short-Term Investments

Antares Pharma Cash and Short-Term Investments Chart (ATRS)

Antares Pharma annual/quarterly Cash and Short-Term Investments from 2000 to 2018.
  • Antares Pharma Cash and Short-Term Investments for the quarter ending December 12, 2018 was $28m a -0.77% decrease of 0m year over year
  • Antares Pharma Cash and Short-Term Investments for the last 12 months ending December 12, 2018 was $28m a -0.77% decrease of 0m year over year
  • Antares Pharma Annual Cash and Short-Term Investments for 2018 was $28m a -13.13% decrease of -4m from 2017
  • Antares Pharma Annual Cash and Short-Term Investments for 2017 was $32m a 12.17% increase of 4m from 2016
  • Antares Pharma Annual Cash and Short-Term Investments for 2016 was $28m a -72.87% decrease of -20m from 2015
Other Balance Sheet Metrics:
  • Antares Pharma Total Assets for the quarter ending December 12, 2018 was $88m a 19.07% increase of 17m year over year
  • Antares Pharma Other Liabilities for the quarter ending September 09, 2018 was $0m a 0.00% decrease of 0m year over year
  • Antares Pharma Total Equity for the quarter ending December 12, 2018 was $39m a 27.57% increase of 11m year over year
View Chart On Koyfin

Quarterly ATRS Cash and Short-Term Investments Data

12/2018$28m
09/2018$28m
06/2018$29m
03/2018$28m
12/2017$32m
09/2017$37m
06/2017$43m
03/2017$24m
12/2016$28m
09/2016$32m

Annual ATRS Cash and Short-Term Investments Data

2018$28m
2017$32m
2016$28m
2015$48m
2014$40m
2013$63m
2012$73m
2011$31m
2010$10m
2009$14m